Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.

Institutions Share
Department of Biochemistry, Emory University, United States of America (USA) 0.57
ReveraGen Biopharma, LLC, United States of America (USA) 0.29
Department of Pharmaceutical Sciences, SUNY Binghamton, United States of America (USA) 0.14

Return